Costs of providing tuberculosis diagnosis and treatment services in Viet Nam

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1035-1040. doi: 10.5588/ijtld.16.0778.

Abstract

Objective: To estimate the cost of providing tuberculosis (TB) diagnosis and treatment packages at different levels of health facilities in Viet Nam.

Design: This was a retrospective costing study from the providers' perspective using a standard costing approach. We included typical services for TB diagnosis and treatment based on standard protocols.

Results: The least expensive TB service was the 6-month isoniazid preventive therapy regimen for latent tuberculous infection provided by district health centres (US$7.20-14.30, accounting for 0.3-0.7% of Viet Nam's per capita gross domestic product [GDP] of US$2052.30 in 2014). The cost of diagnosing and treating a patient with drug-susceptible TB (the most common type of TB) ranged between US$51.20 and US$180.70, and represented 2.5-8.8% of Viet Nam's per capita GDP in 2014. The most expensive TB service was the diagnosis and treatment of a multidrug-resistant TB case (US$1568.20-2391.20), accounting for 76.4-116.5% of Viet Nam's per capita GDP in 2014).

Conclusion: The cost of TB diagnosis and treatment services in Viet Nam varied according to level of health facility, type of TB, different costing options, and different staff cost scenarios.

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use
  • Child
  • Costs and Cost Analysis
  • Health Facilities
  • Humans
  • Isoniazid / therapeutic use
  • Latent Tuberculosis / diagnosis*
  • Latent Tuberculosis / drug therapy*
  • Latent Tuberculosis / economics*
  • Retrospective Studies
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / economics*
  • Vietnam

Substances

  • Antitubercular Agents
  • Isoniazid